Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
3.240
-0.110 (-3.28%)
At close: Jun 1, 2026, 4:00 PM EDT
3.260
+0.020 (0.62%)
Pre-market: Jun 2, 2026, 8:26 AM EDT
Can-Fite BioPharma Stock Forecast
Stock Price Forecast
The 2 analysts that cover Can-Fite BioPharma stock have a consensus rating of "Strong Buy" and an average price target of $6.00, which forecasts a 85.19% increase in the stock price over the next year. The lowest target is $5.00 and the highest is $7.00.
Price Target: $6.00 (+85.19%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Can-Fite BioPharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Nov '25 | Dec '25 | Jan '26 | Mar '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 3 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 3 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Buy Upgrades $7 | Buy | Upgrades | $7 | +116.05% | May 13, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $2.5 → $5 | Buy | Reiterates | $2.5 → $5 | +54.32% | May 12, 2026 |
Financial Forecast
Revenue This Year
n/a
from 405.00K
Decreased by -100.00%
Revenue Next Year
2.81M
EPS This Year
n/a
from -5.97
EPS Next Year
n/a
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | ||
| Avg | n/a | ||
| Low | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -100.0% | ||
| Avg | -100.0% | ||
| Low | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |
Sources: Price targets and consensus ratings provided by TipRanks. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.